These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 22261743

  • 1. Monoubiquitination of nuclear RelA negatively regulates NF-κB activity independent of proteasomal degradation.
    Hochrainer K, Racchumi G, Zhang S, Iadecola C, Anrather J.
    Cell Mol Life Sci; 2012 Jun; 69(12):2057-73. PubMed ID: 22261743
    [Abstract] [Full Text] [Related]

  • 2. The ubiquitin ligase HERC3 attenuates NF-κB-dependent transcription independently of its enzymatic activity by delivering the RelA subunit for degradation.
    Hochrainer K, Pejanovic N, Olaseun VA, Zhang S, Iadecola C, Anrather J.
    Nucleic Acids Res; 2015 Nov 16; 43(20):9889-904. PubMed ID: 26476452
    [Abstract] [Full Text] [Related]

  • 3. p97/VCP promotes Cullin-RING-ubiquitin-ligase/proteasome-dependent degradation of IκBα and the preceding liberation of RelA from ubiquitinated IκBα.
    Schweitzer K, Pralow A, Naumann M.
    J Cell Mol Med; 2016 Jan 16; 20(1):58-70. PubMed ID: 26463447
    [Abstract] [Full Text] [Related]

  • 4. Nuclear IKKbeta is an adaptor protein for IkappaBalpha ubiquitination and degradation in UV-induced NF-kappaB activation.
    Tsuchiya Y, Asano T, Nakayama K, Kato T, Karin M, Kamata H.
    Mol Cell; 2010 Aug 27; 39(4):570-82. PubMed ID: 20797629
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway.
    Sasaki CY, Barberi TJ, Ghosh P, Longo DL.
    J Biol Chem; 2005 Oct 14; 280(41):34538-47. PubMed ID: 16105840
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.
    Saccani S, Marazzi I, Beg AA, Natoli G.
    J Exp Med; 2004 Jul 05; 200(1):107-13. PubMed ID: 15226358
    [Abstract] [Full Text] [Related]

  • 9. Duration of nuclear NF-kappaB action regulated by reversible acetylation.
    Chen Lf, Fischle W, Verdin E, Greene WC.
    Science; 2001 Aug 31; 293(5535):1653-7. PubMed ID: 11533489
    [Abstract] [Full Text] [Related]

  • 10. Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability.
    Park M, Yong Y, Choi SW, Kim JH, Lee JE, Kim DW.
    Nat Cell Biol; 2007 Mar 31; 9(3):287-98. PubMed ID: 17310243
    [Abstract] [Full Text] [Related]

  • 11. Methodology to study NF-κB/RelA ubiquitination in vivo.
    Li H, Starokadomskyy P, Burstein E.
    Methods Mol Biol; 2015 Mar 31; 1280():371-81. PubMed ID: 25736761
    [Abstract] [Full Text] [Related]

  • 12. WSB1/2 target chromatin-bound lysine-methylated RelA for proteasomal degradation and NF-κB termination.
    Zhang J, Yu Y, Zou X, Du Y, Liang Q, Gong M, He Y, Luo J, Wu D, Jiang X, Sinclair M, Tajkhorshid E, Chen HZ, Hou Z, Zheng Y, Chen LF, Yang XD.
    Nucleic Acids Res; 2024 May 22; 52(9):4969-4984. PubMed ID: 38452206
    [Abstract] [Full Text] [Related]

  • 13. Oncoprotein p28 GANK binds to RelA and retains NF-kappaB in the cytoplasm through nuclear export.
    Chen Y, Li HH, Fu J, Wang XF, Ren YB, Dong LW, Tang SH, Liu SQ, Wu MC, Wang HY.
    Cell Res; 2007 Dec 22; 17(12):1020-9. PubMed ID: 18040287
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.
    Fan Y, Mao R, Zhao Y, Yu Y, Sun W, Song P, Shi Z, Zhang D, Yvon E, Zhang H, Fu S, Yang J.
    J Biol Chem; 2009 Oct 23; 284(43):29290-7. PubMed ID: 19706600
    [Abstract] [Full Text] [Related]

  • 15. ATM regulates NF-κB-dependent immediate-early genes via RelA Ser 276 phosphorylation coupled to CDK9 promoter recruitment.
    Fang L, Choudhary S, Zhao Y, Edeh CB, Yang C, Boldogh I, Brasier AR.
    Nucleic Acids Res; 2014 Jul 23; 42(13):8416-32. PubMed ID: 24957606
    [Abstract] [Full Text] [Related]

  • 16. Suppression of p65 phosphorylation coincides with inhibition of IkappaBalpha polyubiquitination and degradation.
    Hu J, Haseebuddin M, Young M, Colburn NH.
    Mol Carcinog; 2005 Dec 23; 44(4):274-84. PubMed ID: 16163708
    [Abstract] [Full Text] [Related]

  • 17. NF-κB is activated in response to temozolomide in an AKT-dependent manner and confers protection against the growth suppressive effect of the drug.
    Caporali S, Levati L, Graziani G, Muzi A, Atzori MG, Bonmassar E, Palmieri G, Ascierto PA, D'Atri S.
    J Transl Med; 2012 Dec 21; 10():252. PubMed ID: 23259744
    [Abstract] [Full Text] [Related]

  • 18. Critical roles of IκBα and RelA phosphorylation in transitional oscillation in NF-κB signaling module.
    Hatanaka N, Seki T, Inoue JI, Tero A, Suzuki T.
    J Theor Biol; 2019 Feb 07; 462():479-489. PubMed ID: 30496749
    [Abstract] [Full Text] [Related]

  • 19. p28(GANK) associates with p300 to attenuate the acetylation of RelA.
    Ren YB, Luo T, Li J, Fu J, Wang Q, Cao GW, Chen Y, Wang HY.
    Mol Carcinog; 2015 Dec 07; 54(12):1626-35. PubMed ID: 25400040
    [Abstract] [Full Text] [Related]

  • 20. Selinexor, a Selective Inhibitor of Nuclear Export (SINE) compound, acts through NF-κB deactivation and combines with proteasome inhibitors to synergistically induce tumor cell death.
    Kashyap T, Argueta C, Aboukameel A, Unger TJ, Klebanov B, Mohammad RM, Muqbil I, Azmi AS, Drolen C, Senapedis W, Lee M, Kauffman M, Shacham S, Landesman Y.
    Oncotarget; 2016 Nov 29; 7(48):78883-78895. PubMed ID: 27713151
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.